China NMPA Drug Inspection - Beijing Linshengtang Pharmaceutical Co., Ltd. - Weiling Granules
China NMPA drug inspection for Beijing Linshengtang Pharmaceutical Co., Ltd. published July 19, 2018. Drug: Weiling Granules. The Beijing Municipal Food and Drug Administration (BMFDA) released an announcement on July 19, 2018, detailing the outc
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Beijing Linshengtang Pharmaceutical Co., Ltd. published July 19, 2018. Drug: Weiling Granules. The Beijing Municipal Food and Drug Administration (BMFDA) released an announcement on July 19, 2018, detailing the outc
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox